Thermo Fisher Scientific Expands Proteomics Portfolio with Olink Acquisition

Thermo Fisher Scientific, a global leader in scientific services, has announced its plan to acquire Olink Holding AB, a provider of next-generation proteomics solutions, for approximately $3.1 billion. The acquisition will enhance Thermo Fisher's capabilities in the high-growth proteomics market, complementing its existing life sciences and mass spectrometry offerings. Olink's proprietary technology, Proximity Extension Assay (PEA), enables rapid and efficient protein analysis, and the company has a library of over 5,300 validated protein biomarker targets. The transaction is expected to be completed by mid-2024, subject to regulatory approvals.